Trust in U.S. Health Agencies: A Year of Erosion since RFK Jr.'s Promises

Sun Mar 15 2026 10:27:08 GMT+0200 (Eastern European Standard Time)

As U.S. Health Secretary Robert F. Kennedy Jr. marks a year in office, evidence suggests a diminishing flow of critical health information, raising concerns about transparency in federal agencies.

Robert F. Kennedy Jr. committed to restoring trust in U.S. health agencies with promises of 'radical transparency.' However, a year later, vital health information has been delayed or cut entirely due to staff layoffs and policy changes, leading to frustration among public health researchers and critics. Numerous examples, including reduced reporting on abortion statistics and smoking rates, highlight a broader trend of diminished data availability under the current administration.

NEW YORK (AP) — A year after promising to enhance transparency within federal health agencies, U.S. Health Secretary Robert F. Kennedy Jr. is facing criticism over a notable decline in the availability of critical health data.

Last year, Kennedy asserted that he would work towards rebuilding trust in these agencies under a framework of 'radical transparency.' This commitment was meant to restore public faith following years of skepticism. Yet, as 12 months have passed, reports indicate that previously available health information is now being delayed, or has ceased to be shared altogether.

Experts point to sweeping layoffs at federal agencies and the protracted government shutdown as contributing factors to the disruption in information flow. Officials have been instructed to remove health agency websites in compliance with directives from the Trump administration, leading to lawsuits aimed at restoring access to critical datasets.

Ariel Beccia, a researcher focusing on the health of LGBTQ youth, expressed her frustration regarding this diminishing access. 'As taxpayers, we anticipate effective public health practices and reliable data,' she noted, highlighting a pervasive sense of loss within the health research community.

According to a spokesman for Kennedy, the assertion that less information is being disseminated is based on flawed premises. He emphasized that Kennedy is leading an unprecedented effort toward transparency, pointing to recent HHS initiatives to disclose previously canceled contracts and repackaged health information.

Reporting on significant health issues has notably slowed. For instance, no annual CDC report on U.S. abortions was published this past November, despite increased demand and pressure to enhance data collection. Instead, officials blamed previous management decisions within the CDC.

Further, the ongoing fight against the overdose epidemic presents another illustration of reduced data availability. Although the government still reports drug death statistics, it has discontinued several monitoring programs, like the Drug Abuse Warning Network, which tracked emergency room visits.

Other health-related campaigns, such as the FDA's tobacco cessation initiatives, have either been cut back significantly or canceled altogether. Concurrently, crucial survey data on smoking rates, which inform many public health policies, has also not been released, correlating the decline in services to a lack of staffing.

Funding cuts and policy shifts have also resulted in inadequate monitoring of food safety and LGBTQ-related health issues, leaving agencies ill-prepared to cope with emerging health trends.

As Trust erodes, public stakeholders are increasingly worried that the government's transparency promises have not materialized as intended. Experts continue to call for a renewal of commitment to open access to health data as a prerequisite to supporting effective public health practice.